Pharmacokinetics of pimozide in adults and children with Tourette's syndrome. 1987

F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
Department of Psychiatry, School of Medicine, University of Pittsburgh, Pennsylvania 15213.

Pimozide is a neuroleptic drug with dopamine receptor and calcium channel blocking activity that is used in the treatment of Tourette's syndrome. A comparison of the pharmacokinetics of pimozide was made in children and adults with Tourette's syndrome. Seven adults (ages 23-39) and four children (ages 6-13) received a single 2-mg oral dose of pimozide and a minimum of nine blood samples were collected over a four-day period. Mean elimination half-life of pimozide in children was 66 hours compared with 111 hours in adults with Tourette's syndrome. Significant interindividual variability of pimozide pharmacokinetics was found in both adults and children with Tourette's syndrome. The pharmacokinetics of pimozide in patients with Tourette's syndrome differs from that reported in adult populations with chronic schizophrenia.

UI MeSH Term Description Entries
D008297 Male Males
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005879 Tourette Syndrome A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79) Gilles de la Tourette Disorder,Gilles de la Tourette's Disease,Tic Disorder, Combined Vocal and Multiple Motor,Chronic Motor and Vocal Tic Disorder,Combined Multiple Motor and Vocal Tic Disorder,Combined Vocal and Multiple Motor Tic Disorder,Gilles De La Tourette's Syndrome,Gilles de la Tourette Syndrome,Multiple Motor and Vocal Tic Disorder, Combined,Tourette Disease,Tourette Disorder,Tourette's Disease,Tourette's Disorder,Tourette's Syndrome,Syndrome, Tourette,Tourettes Disease,Tourettes Disorder,Tourettes Syndrome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
June 1985, Drug intelligence & clinical pharmacy,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
November 1996, Biological psychiatry,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
December 1984, FDA drug bulletin,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
April 2009, The Cochrane database of systematic reviews,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
March 1984, Journal of the American Academy of Child Psychiatry,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
January 1982, Ugeskrift for laeger,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
August 1997, The American journal of psychiatry,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
January 1985, The Medical letter on drugs and therapeutics,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
January 2012, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence,
F R Sallee, and B G Pollock, and R L Stiller, and S Stull, and G Everett, and J M Perel
October 2010, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!